Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction.

MLA

Tisdale, James E., et al. “Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction.” Journal of Clinical Pharmacology, vol. 52, no. 9, Sept. 2012, pp. 1296–305. EBSCOhost, https://doi.org/10.1177/0091270011416939.

APA

Tisdale, J. E., Overholser, B. R., Wroblewski, H. A., Sowinski, K. M., Amankwa, K., Borzak, S., Kingery, J. R., Coram, R., Zipes, D. P., Flockhart, D. A., & Kovacs, R. J. (2012). Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction. Journal of Clinical Pharmacology, 52(9), 1296–1305. https://doi.org/10.1177/0091270011416939

Chicago

Tisdale, James E., Brian R. Overholser, Heather A. Wroblewski, Kevin M. Sowinski, Kwadwo Amankwa, Steven Borzak, Joanna R. Kingery, et al. 2012. “Enhanced Sensitivity to Drug-Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction.” Journal of Clinical Pharmacology 52 (9): 1296–1305. doi:10.1177/0091270011416939.